Christine Gispen‐de Wied

Author

Also Known As

C. Gispen-de Wied, Christine Gispen-De Wied, Christine Gispen-de Wied, Christine Gispen‐de Wied, Gispen-de Wied, Christine

Publications

540

Citations

H-Index

Concepts

All Affiliations

Medicines Evaluation Board Utrecht University University of Groningen University Medical Center Utrecht

About

Christine Gispen‐de Wied is an author at Medicines Evaluation Board specializing in medicine, psychiatry, and maternal health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	224
2	Public Health	2	2	37
3	Social Sciences	1	1	119
4	Neuroscience	1	1	36
5	Obstetrics	1	1	22

Christine Gispen‐de Wied

Publications

321

Citations

H-Index

Page 1

	Year	Citations
Recall and recognition memory deficits in depression Andrew Brand, J. Jolles, Christine Gispen‐de Wied Journal of Affective Disorders Memory RetrievalPsychiatryMedicineMemory LossMemory Assessment	1992	119
HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia Hans Mulder, Dan Cohen, Hans Scheffer, Journal of Clinical Psychopharmacology	2009	82
The partial NMDA agonist D -cycloserine stimulates LH secretion in healthy volunteers Bart N.M. van Berckel, C. Lipsch, Christine Gispen‐de Wied, Psychopharmacology NeuropeptidesAdrenal GlandMedicineHealthy VolunteersPhysiology	1998	36
Insomnia medication: Do published studies reflect the complete picture of efficacy and safety? Taina Mattila, Violeta Stoyanova, André Elferink, European Neuropsychopharmacology SleepPsychiatryPatient SafetyInsomnia MedicationPharmacotherapy	2010	32
Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme Ineke Crijns, Sabine M. J. M. Straus, Michiel Luteijn, Drug Safety InfertilityAbortionReproductive HealthGynecologyMaternal Health	2011	22
Second-trimester exposure to maternal stress is a possible risk factor for psychotic illness in the child J.P. Selten, Rozemarijn van Duursen, Yolanda van der Graaf, Schizophrenia Research PsychopathologyPsychiatryPsychotic DisorderEarly Life ExposureMaternal Complication	1997	15
Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis Stephanie S. Weinreich, Charlotte Vrinten, Marja R. Kuijpers, Orphanet Journal of Rare Diseases	2017	15

Page 1